why choose us

Clinical Trials Search

Showing 6,590 of 132,085 result(s)
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Status: NOT_YET_RECRUITING

Condition: Lung Cancer Diagnosis

Interventions: Subjects who provide informed consent and meet the eligibility criteria will have 50 ml of blood collected and sent to Freenome or Freenome's des

Date: 2023-11-03

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Status: NOT_YET_RECRUITING

Condition: B-cell Acute Lymphoblastic Leukemia (B-ALL)

Interventions: Investigational Product administered via intervenous infusion.

Date: 2023-11-03

Effects of Games on Memory Reconsolidation and Trauma Symptoms

Status: NOT_YET_RECRUITING

Condition: Posttraumatic Stress Disorder

Interventions: Participants randomized to the VST condition will play a visuospatial game (i.e., Tetris).
Participants will be given two minutes to practice Tet

Date: 2023-11-03

Evaluation of the Aurora Xi New Nomogram Software 2.0

Status: NOT_YET_RECRUITING

Condition: Apheresis Related Hypotension

Interventions: Plasma collection with a proprietary plasma collection volume nomogram provides a more individualized approach to determining the volume of plasma col

Date: 2023-11-03

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

Status: Completed

Condition: Schizophrenia

Interventions: CT-156 is a digital therapeutic (DTx) under development to treat patients 18 years of age and older with a diagnosis of schizophrenia under standard o

Date: 2023-11-03

AMX0035 and Progressive Supranuclear Palsy

Status: Completed

Condition: Progressive Supranuclear Palsy

Interventions: Proprietary formulation of sodium phenylbutyrate and taurursodiol

Date: 2023-11-03

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Status: Completed

Condition: Psychosis Associated With Alzheimer's Disease

Interventions: KarXT 20;2 mg (total daily dose [TDD] 60;6 mg) KarXT 30;3 mg (TDD 90;9 mg) KarXT 40;4 mg (TDD 120;12 mg) KarXT 50;5

Date: 2023-11-03

Impact GLP-1 Agonists Following Bariatric

Status: NOT_YET_RECRUITING

Condition: Morbid Obesity

Interventions: Randomized to continue or discontinue GLP-1 receptor agonists after bariatric surgery

Date: 2023-11-02

Cannabidiol Effects on Fear Extinction in Social Phobia

Status: NOT_YET_RECRUITING

Condition: Social Anxiety Disorder

Interventions: Extinction of conditioned fear response

Date: 2023-11-02

Vaginal lIve Biotherapeutic RANdomized Trial

Status: Completed

Condition: Bacterial Vaginosis

Interventions: Tablet containing at least 2 x 10^6 CFU;tablet, and comprised of 6 strains of Lactobacillus crispatus

Date: 2023-11-02